Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT.
Jiménez-Ubieto A, Poza M, Martin-Muñoz A, Ruiz-Heredia Y, Dorado S, Figaredo G, Rosa-Rosa JM, Rodriguez A, Barcena C, Navamuel LP, Carrillo J, Sanchez R, Rufian L, Juárez A, Rodriguez M, Wang C, de Toledo P, Grande C, Mollejo M, Casado LF, Calbacho M, Baumann T, Rapado I, Gallardo M, Sarandeses P, Ayala R, Martínez-López J, Barrio S. Jiménez-Ubieto A, et al. Among authors: poza m. Leukemia. 2023 Mar;37(3):659-669. doi: 10.1038/s41375-022-01803-x. Epub 2023 Jan 3. Leukemia. 2023. PMID: 36596983
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
Sanchez-Pina JM, Rodríguez Rodriguez M, Castro Quismondo N, Gil Manso R, Colmenares R, Gil Alos D, Paciello ML, Zafra D, Garcia-Sanchez C, Villegas C, Cuellar C, Carreño-Tarragona G, Zamanillo I, Poza M, Iñiguez R, Gutierrez X, Alonso R, Rodríguez A, Folgueira MD, Delgado R, Ferrari JM, Lizasoain M, Aguado JM, Ayala R, Martinez-Lopez J, Calbacho M. Sanchez-Pina JM, et al. Among authors: poza m. Eur J Haematol. 2020 Nov;105(5):597-607. doi: 10.1111/ejh.13493. Epub 2020 Aug 11. Eur J Haematol. 2020. PMID: 32710500
Clonal hematopoiesis-defining mutations have no impact on the development of thrombosis in a cohort of patients with myeloid pathology.
Álvarez N, Rodríguez-García A, Morales ML, Gutiérrez M, Montero M, Poza M, López N, Carreño G, Sánchez R, Cedena T, Rapado I, Martínez-López J, Ayala R. Álvarez N, et al. Among authors: poza m. Leuk Res. 2021 Sep;108:106613. doi: 10.1016/j.leukres.2021.106613. Epub 2021 May 8. Leuk Res. 2021. PMID: 34087683 No abstract available.
Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.
Martinez-Lopez J, Alonso R, Wong SW, Rios R, Shah N, Ruiz-Heredia Y, Sanchez-Pina JM, Sanchez R, Bahri N, Zamanillo I, Poza M, Buenache N, Encinas C, Juarez L, Miras F, Collado L, Barrio S, Martin T, Cedena MT, Wolf J. Martinez-Lopez J, et al. Among authors: poza m. J Hematol Oncol. 2021 Aug 17;14(1):126. doi: 10.1186/s13045-021-01135-w. J Hematol Oncol. 2021. PMID: 34404440 Free PMC article.
Impact of IPSS-M implementation in real-life clinical practice.
Zamanillo I, Poza M, Ayala R, Rapado I, Martinez-Lopez J, Cedena MT. Zamanillo I, et al. Among authors: poza m. Front Oncol. 2023 May 18;13:1199023. doi: 10.3389/fonc.2023.1199023. eCollection 2023. Front Oncol. 2023. PMID: 37274292 Free PMC article.
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Jiménez-Ubieto A, Martín-Muñoz A, Poza M, Dorado S, García-Ortiz A, Revilla E, Sarandeses P, Ruiz-Heredia Y, Baumann T, Rodríguez A, Calbacho M, Sánchez PM, Pina JMS, García-Sancho AM, Figaredo G, Rufián L, Rodríguez M, Carneros L, Martínez-Laperche C, Bastos-Oreiro M, Wang C, Cedena MT, Rapado I, de Toledo P, Gallardo M, Valeri A, Ayala R, Martínez-López J, Barrio S. Jiménez-Ubieto A, et al. Among authors: poza m. Front Immunol. 2023 Jun 5;14:1188818. doi: 10.3389/fimmu.2023.1188818. eCollection 2023. Front Immunol. 2023. PMID: 37342332 Free PMC article.
Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease.
Figaredo G, Martín-Muñoz A, Barrio S, Parrilla L, Campos-Martín Y, Poza M, Rufián L, Algara P, De La Torre M, Jiménez Ubieto A, Martínez-López J, Casado LF, Mollejo M. Figaredo G, et al. Among authors: poza m. Cancers (Basel). 2023 Aug 8;15(16):4022. doi: 10.3390/cancers15164022. Cancers (Basel). 2023. PMID: 37627050 Free PMC article.
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Jiménez-Ubieto A, Martín-Muñoz A, Poza M, Dorado S, García-Ortiz A, Revilla E, Sarandeses P, Ruiz-Heredia Y, Baumann T, Rodríguez A, Calbacho M, Sánchez PM, Pina JMS, García-Sancho AM, Figaredo G, Rufián L, Rodríguez M, Carneros L, Martínez-Laperche C, Bastos-Oreiro M, Wang C, Cedena MT, Rapado I, de Toledo P, Gallardo M, Valeri A, Ayala R, Martínez-López J, Barrio S. Jiménez-Ubieto A, et al. Among authors: poza m. Front Immunol. 2023 Aug 16;14:1243241. doi: 10.3389/fimmu.2023.1243241. eCollection 2023. Front Immunol. 2023. PMID: 37662957 Free PMC article.
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Jiménez-Ubieto A, Martín-Muñoz A, Poza M, Dorado S, García-Ortiz A, Revilla E, Sarandeses P, Ruiz-Heredia Y, Baumann T, Rodríguez A, Calbacho M, Sánchez PM, Pina JMS, García-Sancho AM, Figaredo G, Gil-Alós D, Rufián L, Rodríguez M, Carneros L, Martínez-Laperche C, Bastos-Oreiro M, Wang C, Cedena MT, Rapado I, de Toledo P, Gallardo M, Valeri A, Ayala R, Martínez-López J, Barrio S. Jiménez-Ubieto A, et al. Among authors: poza m. Front Immunol. 2024 Jan 10;14:1349296. doi: 10.3389/fimmu.2023.1349296. eCollection 2023. Front Immunol. 2024. PMID: 38268917 Free PMC article.
165 results